Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
20.07.23
/
50%
€31.22
Target price
20.07.24
€49.32
Performance (%)
-29.66%
Price
18.06.24
€21.96
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -29.66%. This prediction currently runs until 20.07.24. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -4.188% | -4.188% |
iShares Core DAX® | -1.189% | -3.063% |
iShares Nasdaq 100 | 3.663% | 8.732% |
iShares Nikkei 225® | -1.422% | -0.414% |
iShares S&P 500 | 2.182% | 4.907% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $55.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat